Bristol-Myers Squibb (BMY) Lowers FY EPS Guidance on Generic PLAVIX Already on Market
Tweet Send to a Friend
Late Friday, Bristol-Myers Squibb (NYSE: BMY) lowered its previously disclosed full year 2006 guidance for fully diluted earnings per share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
